LIGAND PHARMACEUTICALS, INC. <LGND.O>: H.C. WAINWRIGHT RAISES TARGET PRICE TO $358 FROM $289

Reuters2026/08/06 15:59

By:Reuters

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

ENA Price Holds Key Support as Ethena Ecosystem Expands With Maple USDtb Integration

Coinpedia•2026/08/06 20:36

CLARITY Act Runs Out of Time, Will Congress Extend The Recess?

Coinpedia•2026/08/06 20:36

Mercer Intl 2Q Rev $460.3M >MERC

Dow Jones•2026/08/06 20:30

U.S. Fed weekly balance sheet

Reuters•2026/08/06 20:30